HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Q Li Selected Research
Q Li Research Topics
Disease
115
Neoplasms (Cancer)
11/2023 - 01/2000
37
Infections
02/2024 - 02/2001
31
Breast Neoplasms (Breast Cancer)
08/2023 - 02/2000
24
Inflammation (Inflammations)
03/2024 - 01/2000
22
Neoplasm Metastasis (Metastasis)
07/2022 - 09/2000
22
Carcinoma (Carcinomatosis)
07/2022 - 03/2000
18
Type 2 Diabetes Mellitus (MODY)
07/2021 - 05/2001
17
Hepatocellular Carcinoma (Hepatoma)
11/2023 - 09/2000
17
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 03/2001
16
Carcinogenesis
01/2020 - 04/2000
15
Ischemia
01/2019 - 02/2000
13
Fibrosis (Cirrhosis)
12/2023 - 06/2000
13
Hypertension (High Blood Pressure)
12/2023 - 06/2013
13
Body Weight (Weight, Body)
12/2022 - 09/2000
13
Lung Neoplasms (Lung Cancer)
10/2022 - 04/2000
12
Insulin Resistance
11/2023 - 11/2006
12
Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 09/2007
12
Obesity
08/2022 - 07/2002
12
Stomach Neoplasms (Stomach Cancer)
07/2022 - 03/2005
11
Ischemic Stroke
05/2024 - 02/2000
11
Necrosis
07/2021 - 03/2000
10
Stroke (Strokes)
05/2022 - 05/2012
10
Prostatic Neoplasms (Prostate Cancer)
04/2019 - 05/2008
9
Hypoxia (Hypoxemia)
05/2024 - 03/2001
9
Wounds and Injuries (Trauma)
09/2023 - 02/2014
9
Hemorrhage
07/2023 - 09/2015
9
Pain (Aches)
01/2023 - 08/2012
9
Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 09/2009
9
Brain Ischemia (Cerebral Ischemia)
11/2020 - 03/2000
9
Thrombosis (Thrombus)
09/2020 - 04/2000
9
Adenocarcinoma
08/2020 - 04/2000
9
Leukemia
06/2020 - 05/2000
8
Pathologic Constriction (Stenosis)
08/2023 - 02/2001
8
Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020 - 07/2003
8
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 01/2000
7
Liver Cirrhosis (Hepatic Cirrhosis)
11/2023 - 06/2000
7
Burns
09/2023 - 03/2017
7
Myocardial Infarction
07/2023 - 04/2001
7
Hepatitis B
03/2023 - 02/2009
7
Melanoma (Melanoma, Malignant)
11/2022 - 04/2000
7
Sepsis (Septicemia)
08/2022 - 07/2000
7
Reperfusion Injury
12/2016 - 09/2001
6
Anemia
02/2024 - 01/2014
6
Tuberculosis (Tuberculoses)
12/2023 - 10/2000
6
Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2023 - 01/2000
6
Pneumonia (Pneumonitis)
11/2022 - 01/2014
6
Osteoarthritis
01/2022 - 08/2014
6
Heart Failure
08/2020 - 07/2006
5
COVID-19
02/2024 - 08/2020
Drug/Important Bio-Agent (IBA)
55
Proteins (Proteins, Gene)
FDA Link
12/2023 - 01/2000
26
Cytokines
IBA
03/2024 - 01/2000
25
Messenger RNA (mRNA)
IBA
05/2023 - 08/2000
22
Biomarkers (Surrogate Marker)
IBA
02/2024 - 07/2008
19
Glucose (Dextrose)
FDA Link
Generic
01/2023 - 05/2001
16
DNA (Deoxyribonucleic Acid)
IBA
12/2021 - 01/2000
15
Lipids
IBA
11/2023 - 02/2001
15
Long Noncoding RNA
IBA
12/2021 - 01/2011
14
Vaccines
IBA
07/2022 - 04/2000
11
RNA (Ribonucleic Acid)
IBA
05/2024 - 10/2001
11
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2023 - 09/2000
11
Cisplatin (Platino)
FDA Link
Generic
05/2021 - 03/2000
11
MicroRNAs (MicroRNA)
IBA
10/2020 - 03/2012
11
Antigens
IBA
01/2018 - 07/2000
10
Oxygen (Dioxygen)
IBA
12/2023 - 02/2000
8
Chemokines
IBA
12/2023 - 07/2003
8
Hormones (Hormone)
IBA
08/2023 - 07/2000
8
Interleukin-6 (Interleukin 6)
IBA
08/2022 - 01/2000
8
Interleukins
IBA
07/2021 - 06/2003
8
Neuroprotective Agents
IBA
11/2020 - 02/2000
8
Cholesterol
IBA
08/2016 - 02/2001
7
Monoclonal Antibodies
IBA
02/2024 - 02/2008
7
Tyrosine Kinase Inhibitors
IBA
11/2023 - 01/2012
7
LDL Cholesterol
IBA
12/2022 - 02/2016
7
HDL Cholesterol
IBA
12/2022 - 02/2013
7
Immunoglobulin G (IgG)
IBA
08/2022 - 05/2011
7
Catenins
IBA
10/2020 - 04/2014
7
Insulin (Novolin)
FDA Link
01/2020 - 09/2008
7
Enzymes
IBA
12/2015 - 10/2000
6
Platinum
IBA
08/2023 - 03/2000
6
Paclitaxel (Taxol)
FDA Link
Generic
08/2023 - 08/2015
6
Anti-Bacterial Agents (Antibiotics)
IBA
01/2023 - 01/2006
6
Triglycerides (Triacylglycerol)
IBA
12/2022 - 09/2008
6
Glucocorticoids
IBA
08/2022 - 03/2000
6
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2022 - 07/2000
6
Peptides (Polypeptides)
IBA
05/2021 - 01/2000
6
Antibodies
IBA
12/2020 - 05/2011
6
ErbB Receptors (EGF Receptor)
IBA
09/2020 - 09/2001
6
tildrakizumab
IBA
01/2020 - 10/2015
6
Indicators and Reagents (Reagents)
IBA
11/2018 - 04/2004
5
Albumins
IBA
11/2023 - 03/2016
5
Immune Checkpoint Inhibitors
IBA
11/2023 - 07/2020
Therapy/Procedure
71
Therapeutics
09/2023 - 03/2000
26
Drug Therapy (Chemotherapy)
11/2023 - 03/2001
11
Immunotherapy
11/2023 - 10/2000
11
Transplantation
09/2023 - 10/2000
11
Radiotherapy
04/2023 - 02/2007
9
Stents
08/2023 - 08/2012
8
Length of Stay
09/2023 - 12/2000
8
Aftercare (After-Treatment)
09/2022 - 03/2005
5
Renal Dialysis (Hemodialysis)
12/2023 - 11/2016